These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23929763)

  • 1. Predictors of 30-day readmission in patients hospitalized with decompensated heart failure.
    Hernandez MB; Schwartz RS; Asher CR; Navas EV; Totfalusi V; Buitrago I; Lahoti A; Novaro GM
    Clin Cardiol; 2013 Sep; 36(9):542-7. PubMed ID: 23929763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
    Fudim M; O'Connor CM; Dunning A; Ambrosy AP; Armstrong PW; Coles A; Ezekowitz JA; Greene SJ; Metra M; Starling RC; Voors AA; Hernandez AF; Michael Felker G; Mentz RJ
    Eur J Heart Fail; 2018 Feb; 20(2):304-314. PubMed ID: 29082629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
    Samsky MD; Ambrosy AP; Youngson E; Liang L; Kaul P; Hernandez AF; Peterson ED; McAlister FA
    JAMA Cardiol; 2019 May; 4(5):444-453. PubMed ID: 30969316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
    JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure.
    Blecker S; Herrin J; Li L; Yu H; Grady JN; Horwitz LI
    J Am Coll Cardiol; 2019 Mar; 73(9):1004-1012. PubMed ID: 30846093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.
    Moriyama H; Kohno T; Kohsaka S; Shiraishi Y; Fukuoka R; Nagatomo Y; Goda A; Mizuno A; Fukuda K; Yoshikawa T;
    Heart Vessels; 2019 Nov; 34(11):1777-1788. PubMed ID: 31134379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior hospital admission predicts thirty-day hospital readmission for heart failure patients.
    McLaren DP; Jones R; Plotnik R; Zareba W; McIntosh S; Alexis J; Chen L; Block R; Lowenstein CJ; Kutyifa V
    Cardiol J; 2016; 23(2):155-62. PubMed ID: 26779968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
    Dharmarajan K; Hsieh AF; Lin Z; Bueno H; Ross JS; Horwitz LI; Barreto-Filho JA; Kim N; Bernheim SM; Suter LG; Drye EE; Krumholz HM
    JAMA; 2013 Jan; 309(4):355-63. PubMed ID: 23340637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Heart Failure Readmissions.
    Sherer AP; Crane PB; Abel WM; Efird J
    J Cardiovasc Nurs; 2016; 31(2):114-20. PubMed ID: 25513988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Discharge Readiness and Readmission Risk in Patients With Acute Decompensated Heart Failure.
    Oehler A; Kent K; Davis J
    Am J Cardiol; 2018 Dec; 122(12):2086-2094. PubMed ID: 30389090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and correlates of 30 day and 180 day readmission following discharge from a Medicine for the Elderly Rehabilitation unit.
    Hughes LD; Witham MD
    BMC Geriatr; 2018 Aug; 18(1):197. PubMed ID: 30153802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
    Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in 30- and 90-Day Readmission Rates for Heart Failure.
    Khan MS; Sreenivasan J; Lateef N; Abougergi MS; Greene SJ; Ahmad T; Anker SD; Fonarow GC; Butler J
    Circ Heart Fail; 2021 Apr; 14(4):e008335. PubMed ID: 33866827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-cardiovascular disease burden on thirty-day hospital readmission in heart failure patients.
    Kutyifa V; Rice J; Jones R; Mathias A; Yoruk A; Vermilye K; Johnson B; Strawderman R; Lowenstein C
    Cardiol J; 2018; 25(6):691-700. PubMed ID: 30600831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial.
    Kleiner Shochat M; Fudim M; Shotan A; Blondheim DS; Kazatsker M; Dahan I; Asif A; Rozenman Y; Kleiner I; Weinstein JM; Panjrath G; Sobotka PA; Meisel SR
    ESC Heart Fail; 2018 Oct; 5(5):788-799. PubMed ID: 30094959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services.
    Salata BM; Sterling MR; Beecy AN; Ullal AV; Jones EC; Horn EM; Goyal P
    Am J Cardiol; 2018 May; 121(9):1076-1080. PubMed ID: 29548676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry.
    Kitakata H; Kohno T; Kohsaka S; Shiraishi Y; Parizo JT; Niimi N; Goda A; Nishihata Y; Heidenreich PA; Yoshikawa T
    J Am Heart Assoc; 2020 May; 9(10):e014949. PubMed ID: 32378443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.